The9 Limited

NASDAQ:NCTY

Electronic Gaming & Multimedia

Technology
$3.36 +5.05%

+$0.24 today

Market cap
$51.16M
Beta
2.13
P/E (TTM)
-1.0
EPS (TTM)
-$26.43
52W Low $3.14High $11.60

Volume 0.02M

Average 0.07M

NCTY Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

The9 LimitedNASDAQ: NCTY

Research & Development · Q4 FY2025 · quarter ended Dec 2025

Research & development grows 191.0% year over year

Q4 FY2025 research & development of CN¥1.33M rose 191.0% year over year. Over 3 fiscal years it compounded at +59.1% a year.

Context

  • Research & development amounted to 9.1% of revenue in FY2025, up 8.3 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
CN¥1.33M— QoQ
Last fiscal yearDec 2025
CN¥9.8M+1028.6% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+191.0%——
1 year+1028.6%——
3-year CAGR+59.1%——
5-year CAGR——
10-year CAGR——

Research & Development history

CNY · from the income statement

Latest · FY2025
9.8M CNY
Year-over-year change
+1028.6%
4-year CAGR
+50.8%

Research & Development vs competitors

How NCTY compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1028.6% is the highest of 3, against a peer median of -38.2%.
  • Research & development amounts to 9.1% of revenue for NCTY, versus a peer median of 6.2%.
NCTY Competitors
Research & Development for NCTY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NCTYThe9 LimitedFY2025CN¥9.8M CNY+1028.6%+59.1%9.1%
TACTTransAct Technologies IncorporatedLTM Mar 2026$6.45M USD-3.0%-7.9%12.2%
MFImF International LimitedFY2025HK$45.97K HKD-73.4%-16.9%0.1%
Peer median (excluding NCTY) —-38.2%-12.4%6.2%

Competitors are the stored peer set for NCTY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue134.12M104.93M174.02M113.3M107.9M
Cost of Revenue86.89M152.31M213.15M114.92M106.09M
Gross Profit47.22M(47.38M)(39.13M)(1.63M)1.81M
Gross Margin35.2%-45.2%-22.5%-1.4%1.7%
Research & Development1.89M2.43M1.97M868.13K9.8M
Selling, General & Admin311.11M363.43M198.49M160.32M239.77M
Operating Expenses313M614.15M200.46M161.19M249.57M
Depreciation & Amortization46.79M92.99M86.85M62.37M15.12M
EBITDA(219M)(369.62M)(152.74M)(100.44M)(369.85M)
EBITDA Margin-163.3%-352.3%-87.8%-88.7%-342.8%
Operating Income(265.78M)(661.53M)(239.59M)(162.81M)(247.76M)
Operating Margin-198.2%-630.5%-137.7%-143.7%-229.6%
Interest Income0000449K
Interest Expense119.17M23.34M31.38M34.22M23.26M
Other Income / Expenses(145.65M)(31.87M)95.33M88.13M(161.05M)
Income Before Tax(411.43M)(693.41M)(144.26M)(74.69M)(408.81M)
Pre-Tax Margin-306.8%-660.8%-82.9%-65.9%-378.9%
Income Tax Expense0000110K
Net Income(405.91M)(974.86M)(138.79M)(74.46M)(402.45M)
Net Margin-302.7%-929.1%-79.8%-65.7%-373.0%
EPS (Basic)(234.00)(288.00)6.00(15.69)(51.00)
EPS (Diluted)(234.00)(288.00)6.00(15.69)(51.00)
Weighted Avg Shares1.75M3.4M4.93M4.68M7.58M
Weighted Avg Shares (Diluted)1.65M2.4M4.93M4.68M7.58M

The9 Limited

NASDAQ:NCTY

Intrinsic Alpha fair value

Locked

Current Price

$3.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.